Chemours Widens FY2026 Sales Guidance from $5.982B-$6.098B to $5.866B-$6.098B vs $6.044B Est
Chemours (NYSE: CC ) widens FY2026 sales outlook from $5.982 billion-$6.098 billion to $5.866 billion-$6.098 billion vs $6.044 billion estimate.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.